Liver transplantation for Wilson disease

World Journal of Hepatology

Volumn 4, Issue 1, 2012, Pages 5-10

  Catana, Andreea M ^a   Medici, Valentina ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Contraindications; Copper; Indications; Liver transplantation; Wilson disease

Indexed keywords

EID: 84867006907     PISSN: None     EISSN: 19485182     Source Type: Journal    
DOI: 10.4254/wjh.v4.i1.5     Document Type: Review

References (57)

1. DuBois RS, Rodgerson DO, Martineau G, Shroter G, Giles G, Lilly J, Halgrimson CG, Starzl TE, Sternlieb I, Scheinberg IH. Orthotopic liver transplantation for Wilson's disease. Lancet 1971; 1: 505-508
2. Arnon R, Annunziato R, Schilsky M, Miloh T, Willis A, Sturdevant M, Sakworawich A, Suchy F, Kerkar N. Liver transplantation for children with Wilson disease: comparison of outcomes between children and adults. Clin Transplant 2011; 25: E52-60
3. Gitlin JD. Wilson disease. Gastroenterology 2003; 125: 1868-1877
4. Arnon R, Kerkar N, Davis MK, Anand R, Yin W, Gonzalez-Peralta RP. Liver transplantation in children with metabolic diseases: the studies of pediatric liver transplantation experience. Pediatr Transplant 2010; 14: 796-805
5. Schoen RE, Sternlieb I. Clinical aspects of Wilson's disease. Am J Gastroenterol 1990; 85: 1453-1457
6. Beyersdorff A, Findeisen A. Morbus Wilson: Case report of a two-year-old child as first manifestation. Scand J Gastroenterol 2006; 41: 496-497
7. Ala A, Borjigin J, Rochwarger A, Schilsky M. Wilson disease in septuagenarian siblings: Raising the bar for diagnosis. Hepatology 2005; 41: 668-670
8. Martin AP, Bartels M, Redlich J, Hauss J, Fangmann J. A single-center experience with liver transplantation for Wilson's disease. Clin Transplant 2008; 22: 216-221
9. Walshe JM. Cause of death in Wilson disease. Mov Disord 2007; 22: 2216-2220
10. Scheinberg IH, Sternlieb I. Wilson disease and idiopathic copper toxicosis. Am J Clin Nutr 1996; 63: 842S-845S
11. Ala A, Walker AP, Ashkan K, Dooley JS, Schilsky ML. Wilson's disease. Lancet 2007; 369: 397-408
12. Kasai N, Miyoshi I, Osanai T, Yamashita T, Kamimura E, Yoshida MC. Effects of sex hormones on fulminant hepatitis in LEC rats: a model of Wilson's disease. Lab Anim Sci 1992; 42: 363-368
13. Ostapowicz G, Fontana RJ, Schiødt FV, Larson A, Davern TJ, Han SH, McCashland TM, Shakil AO, Hay JE, Hynan L, Crippin JS, Blei AT, Samuel G, Reisch J, Lee WM. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954
14. McCullough AJ, Fleming CR, Thistle JL, Baldus WP, Ludwig J, McCall JT, Dickson ER. Diagnosis of Wilson's disease presenting as fulminant hepatic failure. Gastroenterology 1983; 84: 161-167
15. Schilsky ML, Sternlieb I. Overcoming obstacles to the diagnosis of Wilson's disease. Gastroenterology 1997; 113: 350-353
16. Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47: 2089-2111
17. Berman DH, Leventhal RI, Gavaler JS, Cadoff EM, Van Thiel DH. Clinical differentiation of fulminant Wilsonian hepatitis from other causes of hepatic failure. Gastroenterology 1991; 100: 1129-1134
18. Korman JD, Volenberg I, Balko J, Webster J, Schiodt FV, Squires RH, Fontana RJ, Lee WM, Schilsky ML. Screening for Wilson disease in acute liver failure: a comparison of currently available diagnostic tests. Hepatology 2008; 48: 1167-1174
19. Eisenbach C, Sieg O, Stremmel W, Encke J, Merle U. Diagnostic criteria for acute liver failure due to Wilson disease. World J Gastroenterol 2007; 13: 1711-1714
20. Medici V, Mirante VG, Fassati LR, Pompili M, Forti D, Del Gaudio M, Trevisan CP, Cillo U, Sturniolo GC, Fagiuoli S. Liver transplantation for Wilson's disease: The burden of neurological and psychiatric disorders. Liver Transpl 2005; 11: 1056-1063
21. Sallie R, Katsiyiannakis L, Baldwin D, Davies S, O'Grady J, Mowat A, Mieli-Vergani G, Williams R. Failure of simple biochemical indexes to reliably differentiate fulminant Wilson's disease from other causes of fulminant liver failure. Hepatology 1992; 16: 1206-1211
22. Eghtesad B, Nezakatgoo N, Geraci LC, Jabbour N, Irish WD, Marsh W, Fung JJ, Rakela J. Liver transplantation for Wilson's disease: a single-center experience. Liver Transpl Surg 1999; 5: 467-474
23. Tissières P, Chevret L, Debray D, Devictor D. Fulminant Wilson's disease in children: appraisal of a critical diagnosis. Pediatr Crit Care Med 2003; 4: 338-343
24. Koppikar S, Dhawan A. Evaluation of the scoring system for the diagnosis of Wilson's disease in children. Liver Int 2005; 25: 680-681
25. Sen S, Felldin M, Steiner C, Larsson B, Gillett GT, Olausson M, Williams R, Jalan R. Albumin dialysis and Molecular Adsorbents Recirculating System (MARS) for acute Wilson's disease. Liver Transpl 2002; 8: 962-967
26. Collins KL, Roberts EA, Adeli K, Bohn D, Harvey EA. Single pass albumin dialysis (SPAD) in fulminant Wilsonian liver failure: a case report. Pediatr Nephrol 2008; 23: 1013-1016
27. Jhang JS, Schilsky ML, Lefkowitch JH, Schwartz J. Therapeutic plasmapheresis as a bridge to liver transplantation in fulminant Wilson disease. J Clin Apher 2007; 22: 10-14
28. Asfaha S, Almansori M, Qarni U, Gutfreund KS. Plasmapheresis for hemolytic crisis and impending acute liver failure in Wilson disease. J Clin Apher 2007; 22: 295-298
29. Mitzner SR, Stange J, Klammt S, Risler T, Erley CM, Bader BD, Berger ED, Lauchart W, Peszynski P, Freytag J, Hickstein H, Loock J, Löhr JM, Liebe S, Emmrich J, Korten G, Schmidt R. Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. Liver Transpl 2000; 6: 277-286
30. Sen S, Mookerjee RP, Davies NA, Williams R, Jalan R. Review article: the molecular adsorbents recirculating system (MARS) in liver failure. Aliment Pharmacol Ther 2002; 16 Suppl 5: 32-38
31. Manz T, Ochs A, Bisse E, Strey C, Grotz W. Liver support--a task for nephrologists? Extracorporeal treatment of a patient with fulminant Wilson crisis. Blood Purif 2003; 21: 232-236
32. Saliba F. The Molecular Adsorbent Recirculating System (MARS) in the intensive care unit: a rescue therapy for patients with hepatic failure. Crit Care 2006; 10: 118
33. Rifai K, Manns MP. Review article: clinical experience with Prometheus. Ther Apher Dial 2006; 10: 132-137
34. Demetriou AA, Brown RS, Busuttil RW, Fair J, McGuire BM, Rosenthal P, Am Esch JS, Lerut J, Nyberg SL, Salizzoni M, Fagan EA, de Hemptinne B, Broelsch CE, Muraca M, Salmeron JM, Rabkin JM, Metselaar HJ, Pratt D, De La Mata M, McChesney LP, Everson GT, Lavin PT, Stevens AC, Pitkin Z, Solomon BA. Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg 2004; 239: 660-667; discussion 667-670
35. Mason AL, Marsh W, Alpers DH. Intractable neurological Wilson's disease treated with orthotopic liver transplantation. Dig Dis Sci 1993; 38: 1746-1750
36. Bax RT, Hässler A, Luck W, Hefter H, Krägeloh-Mann I, Neuhaus P, Emmrich P. Cerebral manifestation of Wilson's disease successfully treated with liver transplantation. Neurology 1998; 51: 863-865
37. Stracciari A, Tempestini A, Borghi A, Guarino M. Effect of liver transplantation on neurological manifestations in Wilson disease. Arch Neurol 2000; 57: 384-386
38. Kassam N, Witt N, Kneteman N, Bain VG. Liver transplantation for neuropsychiatric Wilson disease. Can J Gastroenterol 1998; 12: 65-68
39. Wang XH, Cheng F, Zhang F, Li XC, Kong LB, Li GQ, Li J, Qian XF. Living-related liver transplantation for Wilson's disease. Transpl Int 2005; 18: 651-656
40. Marin C, Robles R, Parrilla G, Ramírez P, Bueno FS, Parrilla P. Liver transplantation in Wilson's disease: are its indications established? Transplant Proc 2007; 39: 2300-2301
41. Geissler I, Heinemann K, Rohm S, Hauss J, Lamesch P. Liver transplantation for hepatic and neurological Wilson's disease. Transplant Proc 2003; 35: 1445-1446
42. Wang XH, Zhang F, Li XC, Cheng F, Li J, Li GQ, Huang J. Eighteen living related liver transplants for Wilson's disease: a single-center. Transplant Proc 2004; 36: 2243-2245
43. Roberts EA, Schilsky ML. A practice guideline on Wilson disease. Hepatology 2003; 37: 1475-1492
44. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, D'Amico G, Dickson ER, Kim WR. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470
45. Cheng F, Li GQ, Zhang F, Li XC, Sun BC, Kong LB, Pu LY, Wang K, Qian XF, You W, Wang XH. Outcomes of living-related liver transplantation for Wilson's disease: a single-center experience in China. Transplantation 2009; 87: 751-757
46. Schilsky ML. Diagnosis and treatment of Wilson's disease. Pediatr Transplant 2002; 6: 15-19
47. Okada T, Shiono Y, Hayashi H, Satoh H, Sawada T, Suzuki A, Takeda Y, Yano M, Michitaka K, Onji M, Mabuchi H. Mutational analysis of ATP7B and genotype-phenotype correlation in Japanese with Wilson's disease. Hum Mutat 2000; 15: 454-462
48. Takeyama Y, Yokoyama K, Takata K, Tanaka T, Sakurai K, Matsumoto T, Iwashita H, Ueda S, Hirano G, Hanano T, Nakane H, Morihara D, Nishizawa S,Yoshikane M, Anan A, Kakumitsu S, Kitamura Y, Sakamoto M, Irie M, Iwata K, Shakado S, Sohda T, Watanabe H, Hirose S, Hayashi H, Noritomi T, Yamashita Y, Sakisaka S. Clinical features of Wilson disease: Analysis of 10 cases. Hepatol Res 2010; 40: 1204-1211
49. Yoshitoshi EY, Takada Y, Oike F, Sakamoto S, Ogawa K, Kanazawa H, Ogura Y, Okamoto S, Haga H, Ueda M, Egawa H, Kasahara M, Tanaka K, Uemoto S. Long-term outcomes for 32 cases of Wilson's disease after living-donor liver transplantation. Transplantation 2009; 87: 261-267
50. Park YK, Kim BW, Wang HJ, Kim MW. Auxiliary partial orthotopic living donor liver transplantation in a patient with Wilson's disease: a case report. Transplant Proc 2008; 40: 3808-3809
51. Kasahara M, Takada Y, Egawa H, Fujimoto Y, Ogura Y, Ogawa K, Kozaki K, Haga H, Ueda M, Tanaka K. Auxiliary partial orthotopic living donor liver transplantation: Kyoto University experience. Am J Transplant 2005; 5: 558-565
52. Mito M, Kusano M, Kawaura Y. Hepatocyte transplantation in man. Transplant Proc 1992; 24: 3052-3053
53. Wege H, Le HT, Chui MS, Liu L, Wu J, Giri R, Malhi H, Sappal BS, Kumaran V, Gupta S, Zern MA. Telomerase reconstitution immortalizes human fetal hepatocytes without disrupting their differentiation potential. Gastroenterology 2003; 124: 432-444
54. Shirahashi H, Wu J, Yamamoto N, Catana A, Wege H, Wager B, Okita K, Zern MA. Differentiation of human and mouse embryonic stem cells along a hepatocyte lineage. Cell Transplant 2004; 13: 197-211
55. Schilsky ML. Wilson disease: current status and the future. Biochimie 2009; 91: 1278-1281
56. Grompe M. Therapeutic liver repopulation for the treatment of metabolic liver diseases. Hum Cell 1999; 12: 171-180
57. Muraca M, Gerunda G, Neri D, Vilei MT, Granato A, Feltracco P, Meroni M, Giron G, Burlina AB. Hepatocyte transplantation as a treatment for glycogen storage disease type 1a. Lancet 2002; 359: 317-318